Sign Up Today and Learn More About CoreMedic GmbH Stock

Invest in or calculate the value of your shares in CoreMedic GmbH or other pre-IPO companies through EquityZen's platform.

Get Started

View More Companies

CoreMedic GmbH Stock (COGM)

CoreMedic develops and manufactures devices to address the treatment of heart valve diseases. Lead product: ChordArt TMVr - System

Invest Now Sell Shares

About CoreMedic GmbH Stock

Founded

2012

Industries

Software, Artificial Intelligence, Data and Analytics

CoreMedic was initiated in 2012 as a spin-out of the Heart Center of University of Bern, Switzerland, in order to develop an innovative treatment concept for mitral valve regurgitation (MR). The initiators of CoreMedic had a simple but challenging idea: to combine the least invasive treatment option for MR, replacement of mitral chords, and the least invasive operational procedure into one new system: ChordArt. In 2017, the development of ChordArt had progressed towards first use in a human trial, enabling CoreMedic to attract institutional financing. The company moved to RIZ-innovation center at Radolfzell, Germany, located at Lake Constance close to the Swiss border within the leading medical technology cluster of Tuttlingen, Germany. Following successful conclusion of the first human trial of ChordArt in 2018, and two-year data confirming the powerful treatment effect of the ChordArt implant in patients with severe MR, CoreMedic GmbH is tirelessly working to make the ChordArt TMVr system available to patients.

Leadership team at CoreMedic GmbH

CEO

Thomas Bauer

CFO

Rainer Hoegg

Join now and verify your accreditation status to gain access to:

CoreMedic GmbH current valuation
CoreMedic GmbH stock price
Available deals in CoreMedic GmbH and all other companies
Deal offering documents
EquityZen's proprietary data and insights, including

Cap tables, which include funding history by Share Class and Liquidity Preferences
Company Highlights
Business Model
Risk Factors

Join Now

How to invest in CoreMedic GmbH stock?

Accredited investors can buy pre-IPO stock in companies like CoreMedic GmbH through EquityZen funds. These investments are made available by existing CoreMedic GmbH shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell CoreMedic GmbH stock?

Shareholders can sell their CoreMedic GmbH stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."

More Like CoreMedic GmbH

CALS

Caris Life Sciences

AI-Powered Precision Oncology

SPAX

SpaceX

Space Exploration and Transportation

OMHE

Omada Health

Digital Behavioral Medicine

COLH

Collective Health

Employee Health Insurance Platform

ZOCD

Zocdoc

Zocdoc allows patients to search for in-network doctors, book appointments online, read patient reviews, and manage their healthcare information. The platform focuses on providing a convenient and user-friendly experience for patients to navigate healthcare services.

CARB

Carbon

3D Printing & Polymer Manufacturing

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen Inc. was awarded a 2023 Fintech Breakthrough Award by Tech Breakthrough LLC on or about March 23, 2023, based on the prior calendar year and covering calendar year 2023, and has compensated Tech Breakthrough LLC for use of its name and logo in connection with the award. Tech Breakthrough LLC is a third party and has no affiliation with EquityZen.

EquityZen created the ticker symbols referenced on this page for use solely on the EquityZen platform. They do not refer to any publicly traded stock. EquityZen does not have an affiliation with, formal relationship with, or endorsement from any of the companies featured and none of the statements on the site should be attributed to those companies.

“Market Activity” and other transactional data displayed on this website is compiled by EquityZen and is confidential and historical in nature. Unauthorized use, distribution or reproduction is prohibited. Transactional information does not guarantee future investment results. EquityZen cannot guarantee finding or approving a transaction at any displayed price.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2024 EquityZen Inc. All rights reserved.